- Telehealth Visits
- Insurance plan information
Peter A. Ljubenkov, MD
Neurology • Memory and Cognitive Disorders Neurology- Telehealth Visits
- Insurance plan information
Peter A. Ljubenkov, MD
Neurology • Memory and Cognitive Disorders Neurology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Peter A. Ljubenkov is a behavioral neurologist who specializes in caring for patients experiencing memory, language and behavioral changes due to neurological conditions, such as Alzheimer's disease, Lewy body dementia and other causes of dementia. He has special expertise in diagnosing and treating frontotemporal dementia (a group of neurodegenerative diseases that affect the frontal and temporal lobes) and related conditions, including progressive supranuclear palsy and corticobasal degeneration. Ljubenkov also serves as the associate fellowship director of the UCSF Memory and Aging Center's Behavioral Neurology Training Program fellowship, which trains doctors for careers in research and clinical care involving patients with dementia.
In research, Ljubenkov is active in clinical therapeutic trials, studies enrolling human participants to explore new potential treatments for patients with dementia.
Ljubenkov earned his medical degree at Lewis Katz School of Medicine at Temple University. He completed a residency in neurology at the University of California, San Diego, followed by a fellowship in behavioral neurology at UCSF.
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Behavioral Neurology, University of CA at San Francisco - Neurology GME
Residency
- Neurology, University of California Medical Center San Diego
Internship
- Internal Medicine, University of California - Irvine Medical Center
Degree
- MD, Lewis Katz School of Medicine at Temple University
My expertise
Locations
My research
Clinical trials
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 PathologyOpens in a new window
Recruiting
Assess adverse events during 6 months administration of Verdiperstat or Placebo
Publications
Showing 1-6 of 17 reviews
- January 28, 20265 out of 5 Stars
Dr Peter was wonderful. I am so happy he Is my doctor.
- January 27, 20265 out of 5 Stars
Excellent physician with deep knowledge of the issues and great suggestions for what's next.
- January 20, 20265 out of 5 Stars
Dr. Ljubenkov always seems to go above and beyond.
- January 15, 20265 out of 5 Stars
I enjoy working with Dr. Peter in Neurology
- December 18, 20255 out of 5 Stars
We feel it is a privilege to be able to see someone of the caliber of Dr Peter Ljubenkov. He Is not only extremely knowledgeable, but he Is kind, courteous, respectful, friendly and really understands how to listen to and how to treat patients with dementia.
- November 10, 20255 out of 5 Stars
Peter was very empathetic and has made me feel much more hopeful
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.